Show simple item record

dc.contributor.authorKalantar, R
dc.contributor.authorLin, G
dc.contributor.authorWinfield, JM
dc.contributor.authorMessiou, C
dc.contributor.authorLalondrelle, S
dc.contributor.authorBlackledge, MD
dc.contributor.authorKoh, D-M
dc.date.accessioned2022-01-07T14:06:33Z
dc.date.available2022-01-07T14:06:33Z
dc.date.issued2021-10-22
dc.identifier.citationDiagnostics (Basel, Switzerland), 2021, 11 (11)
dc.identifier.issn2075-4418
dc.identifier.urihttps://repository.icr.ac.uk/handle/internal/4949
dc.identifier.eissn2075-4418
dc.identifier.eissn2075-4418
dc.identifier.doi10.3390/diagnostics11111964
dc.description.abstractThe recent rise of deep learning (DL) and its promising capabilities in capturing non-explicit detail from large datasets have attracted substantial research attention in the field of medical image processing. DL provides grounds for technological development of computer-aided diagnosis and segmentation in radiology and radiation oncology. Amongst the anatomical locations where recent auto-segmentation algorithms have been employed, the pelvis remains one of the most challenging due to large intra- and inter-patient soft-tissue variabilities. This review provides a comprehensive, non-systematic and clinically-oriented overview of 74 DL-based segmentation studies, published between January 2016 and December 2020, for bladder, prostate, cervical and rectal cancers on computed tomography (CT) and magnetic resonance imaging (MRI), highlighting the key findings, challenges and limitations.
dc.formatElectronic
dc.languageeng
dc.language.isoeng
dc.publisherMDPI
dc.rights.urihttps://creativecommons.org/licenses/by/4.0
dc.titleAutomatic Segmentation of Pelvic Cancers Using Deep Learning: State-of-the-Art Approaches and Challenges.
dc.typeJournal Article
dcterms.dateAccepted2021-10-19
rioxxterms.versionVoR
rioxxterms.versionofrecord10.3390/diagnostics11111964
rioxxterms.licenseref.urihttps://creativecommons.org/licenses/by/4.0
rioxxterms.licenseref.startdate2021-10-22
rioxxterms.typeJournal Article/Review
dc.relation.isPartOfDiagnostics (Basel, Switzerland)
pubs.issue11
pubs.notesNot known
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging/Computational Imaging
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging/Gynaecological Cancer
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging/Gynaecological Cancer/Gynaecological Cancer (hon.)
pubs.organisational-group/ICR/Primary Group/Royal Marsden Clinical Units
pubs.organisational-group/ICR/Students
pubs.organisational-group/ICR/Students/PhD and MPhil
pubs.organisational-group/ICR/Students/PhD and MPhil/19/20 Starting Cohort
pubs.publication-statusPublished
pubs.volume11
pubs.embargo.termsNot known
icr.researchteamComputational Imaging
icr.researchteamGynaecological Cancer
dc.contributor.icrauthorKalantar, Reza
dc.contributor.icrauthorBlackledge, Matthew


Files in this item

Thumbnail

This item appears in the following collection(s)

Show simple item record

https://creativecommons.org/licenses/by/4.0
Except where otherwise noted, this item's license is described as https://creativecommons.org/licenses/by/4.0